Insider Trading History of Amgen Inc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Amgen Inc since 2013. This trader's CIK number is 318154. At the time of last reporting, Amgen Inc was the Officer of Neumora Therapeutics, Inc.. (stock ticker symbol NMRA). Also see all insider trading activities at Neumora Therapeutics, Inc..

Note that in the past AMGEN INC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Neumora Therapeutics, Inc. (NMRA) by Amgen Inc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 NMRA 1,764,705 $29,999,985 0 $0 0 $0

Yearly summary of insider trading at Beigene, Ltd. (BGNE) by Amgen Inc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 BGNE 165,529 $50,000,020 0 $0 0 $0

Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Amgen Inc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 EPZM 16,666 $249,990 0 $0 0 $0


Insider trading activities at 3 companies by Amgen Inc:

1. Neumora Therapeutics, Inc. (NMRA)

2. Beigene, Ltd. (BGNE)

3. Epizyme, Inc. (EPZM)

Table 1. Insider trading of Neumora Therapeutics, Inc. (NMRA) by Amgen Inc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-09-19 NMRA Buy 1,764,705 17.00 29,999,985

Table 2. Insider trading of Beigene, Ltd. (BGNE) by Amgen Inc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-09-10 BGNE Buy 165,529 302.06 50,000,020

Table 3. Insider trading of Epizyme, Inc. (EPZM) by Amgen Inc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-06-05 EPZM Buy 16,666 15.00 249,990

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Amgen Inc (Officer of Neumora Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.